Clinical Trial: To Evaluate the Efficacy and Safety of Initial Combination Therapy With DWP16001 and DWC202518 Compared to DWP16001 Monotherapy and DWC202518 Monotherapy in Patients With Type 2 Diabetes Mellitus

U.S., June 3 -- ClinicalTrials.gov registry received information related to the study (NCT07619833) titled 'To Evaluate the Efficacy and Safety of Initial Combination Therapy With DWP16001 and DWC202518 Compared to DWP16001 Monotherapy and DWC202518 Monotherapy in Patients With Type 2 Diabetes Mellitus' on May 26.

Brief Summary: This study aims to evaluate the efficacy and safety of initial combination therapy with DWP16001 and DWC202518 compared to DWP16001 monotherapy and DWC202518 monotherapy in patients with Type 2 Diabetes Mellitus

Study Start Date: June, 2026

Study Type: INTERVENTIONAL

Condition: T2DM (Type 2 Diabetes Mellitus)

Intervention: DRUG: DWP16001

DWP16001 0.3mg, Tablets, Orally, Once daily

DRUG: DWC202518

DWC202518...